Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05RVA
|
||||
Former ID |
DIB000432
|
||||
Drug Name |
CFG920
|
||||
Indication | Metastatic castration-resistant prostate cancer [ICD9: 140-229, 185; ICD10:C61] | Phase 1/2 | [532436] | ||
Company |
Novartis pharmaceuticals
|
||||
Structure |
Download2D MOL |
||||
Target and Pathway | |||||
Target(s) | 17 alpha-hydroxylase-C17, 20-lyase | Target Info | Inhibitor | [532436] | |
PathWhiz Pathway | Androgen and Estrogen Metabolism | ||||
Steroidogenesis | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.